Bone Biologics Corp (BBLGW) Interest & Investment Income (2014 - 2025)

Bone Biologics (BBLGW) has reported Interest & Investment Income for 4 consecutive years, with $47964.0 the latest figure, recorded in Q4 2025.

• In Q4 2025, Interest & Investment Income rose 136.7% year-over-year to $47964.0; the TTM figure through Dec 2025 stood at $121982.0 (up 119.16% YoY), while the FY2025 annual figure was $121984.0, up 119.16% from the prior year.
• Interest & Investment Income grew to $47964.0 in Q4 2025 per BBLGW's latest filing, from $47325.0 in the prior quarter.
• Across five years, Interest & Investment Income topped out at $47964.0 in Q4 2025 and bottomed at $255.0 in Q1 2024.
• Historically, Interest & Investment Income has averaged $16268.5 across 3 years, with a median of $15147.0 in 2024.
• On a YoY basis, Interest & Investment Income climbed as much as 7758.43% in 2025 and fell as far as 56.07% in 2025.
• Bone Biologics' Interest & Investment Income stood at $349.0 in 2023, then surged by 5706.3% to $20264.0 in 2024, then soared by 136.7% to $47964.0 in 2025.
• Business Quant data shows BBLGW's Interest & Investment Income at $47964.0 in Q4 2025, $47325.0 in Q3 2025, and $6654.0 in Q2 2025.